| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4280190
Max Phase: Preclinical
Molecular Formula: C25H23ClN2O
Molecular Weight: 402.93
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cc2nc(C(C)(C)O)cc(-c3ccccc3Cl)c2c(C)c1-c1ccncc1
Standard InChI: InChI=1S/C25H23ClN2O/c1-15-13-21-24(16(2)23(15)17-9-11-27-12-10-17)19(14-22(28-21)25(3,4)29)18-7-5-6-8-20(18)26/h5-14,29H,1-4H3
Standard InChI Key: OARKUKXJGKPHGK-UHFFFAOYSA-N
Associated Targets(non-human)
Long-chain-fatty-acid--AMP ligase FadD32 36 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 402.93 | Molecular Weight (Monoisotopic): 402.1499 | AlogP: 6.46 | #Rotatable Bonds: 3 |
| Polar Surface Area: 46.01 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 13.94 | CX Basic pKa: 5.18 | CX LogP: 6.15 | CX LogD: 6.15 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.43 | Np Likeness Score: -0.53 |
References
| 1. Fang C, Lee KK, Nietupski R, Bates RH, Fernandez-Menendez R, Lopez-Roman EM, Guijarro-Lopez L, Yin Y, Peng Z, Gomez JE, Fisher S, Barros-Aguirre D, Hubbard BK, Serrano-Wu MH, Hung DT.. (2018) Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors., 28 (22): [PMID:30316633] [10.1016/j.bmcl.2018.09.037] |
Source
Source(1):